ExitHealthcare
GSK to acquire Deerfield-backed Nuvalent
The platform investment centers on a precision oncology company backed by Deerfield Management, in a transaction valued at up to $10, with transaction terms undisclosed in the announcement.
- Target
- Nuvalent
- Seller
- Deerfield Management
- Source
- PR Newswire